Search - tctmd.com

Displaying 181 - 200 of 295

Sort: Relevancy | Date

Presentation TCT 2012

Sirolimus-Eluting Stent (Svelte Medical) Program Update

Presenter: Mark Webster

October 23, 2012

News Industry News

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

October 23, 2012

News Conference News TCT 2012

Large Study Finds Comparable 8-Month TVF for PES, SES

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

News Conference News TCT 2012

Several Trials Highlight DES Comparisons

October 22, 2012

Presentation TCT 2012

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

Presenter: Masato Nakamura

October 22, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

News Daily News

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Yael L. Maxwell

August 23, 2012

Presentation

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

August 21, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

Presentation

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Presenter: Takeshi Kimura

July 27, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

El Xience V No es Inferior al Cypher en PCI Primarias

July 24, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

Advertisement

Sirolimus-Eluting Stent (Svelte Medical) Program Update

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

Large Study Finds Comparable 8-Month TVF for PES, SES

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Several Trials Highlight DES Comparisons

J-DESSERT: A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents in Patients with and without Diabetes

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Stent Fractures Persist Among Newer-Generation Devices

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Xience V Noninferior to Cypher for Primary PCI

El Xience V No es Inferior al Cypher en PCI Primarias

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content